- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Weekly Round-Up: Tilray Posts US$61.6 Million Loss
The leading cannabis grower faced another quarterly downturn, reporting a loss of over US$60 million.
A leading cannabis grower continues to struggle financially and was recently demoted by an analyst.
Also this past week, the state of Connecticut began selling recreational cannabis.
Keep reading to find out more cannabis highlights from the past five days.
Tilray reports quarterly loss, loses top pick status
The Canadian cannabis market continues to struggle, with a leading publicly traded company posting a severe loss.
On Monday (January 9), Tilray Brands (NASDAQ:TLRY,TSX:TLRY) shared results for the second quarter of its 2023 fiscal year, reporting a quarterly net loss of US$61.6 million, or US$0.11 per share, for the period ended November 30, 2022.
In the same quarter last year, the firm reported a net income line of US$5.8 million.
In a call with analysts, Tilray CEO Irwin Simon expressed annoyance at the lack of progress in US cannabis reform, which he believes could unlock the American market for Canadian operators such as Tilray. "I'm frustrated that legalization, whether it's SAFE Bank, whether it's MORE Act, whether it's descheduling — nothing has happened within cannabis," he said.
Additionally, the executive speculated that progress for adult cannabis sales in Germany, another market Tilray is interested in, would be moving faster were it not for the current conflict in Europe.
"I'm sure if Ukraine didn't happen, Germany might be legal today, but we're ready and will be ready," he said.
Tilray's loss was noticed by market participants — BNN Bloomberg reported that the top cannabis analyst at CIBC's (TSX:CM) investment arm has changed his top cannabis pick from Tilray to Village Farms International (NASDAQ:VFF).
Recently, Charles Taerk, president and CEO of Faircourt Asset Management, told the Investing News Network that Village Farms is his top pick for cannabis growers in Canada because of its agricultural know-how.
Simon noted that Tilray continues to work on streamlining activities. “We are close to achieving our increased annualized cost savings target of US$130 million, consistent with our commitment to building a lean, efficient, and dynamic business that will realize tangible and immediate benefits as the market improves,” he said.
Connecticut launches recreational cannabis sales
The state of Connecticut opened its doors to recreational cannabis sales this past week. On Tuesday (January 10), legal sales of adult-use cannabis products officially kicked off with 40 dispensaries in the state.
State regulators celebrated the launch, which brought US$251,276 in sales and a “smooth” process in stores, according to a tweet from the Connecticut Department of Consumer Protection (DCP).
“We have had no reported issues at any of our retailers, and we are proud of the successful launch of the regulated adult-use market,” Michelle H. Seagull, commissioner of the DCP, said.
In statements, a few cannabis operators celebrated the opening of the Connecticut market.
“We expect Connecticut will be a booming adult-use market,” Peter Caldini, CEO of Acreage Holdings (CSE:ACRG.A.U,OTCQX:ACRHF), said.
For his part, Matt Darin, CEO of Curaleaf (CSE:CURA,OTCQX:CURLF), commended the governor of Connecticut, Ned Lamont, for his leadership in getting the state’s cannabis policies to where they are now.
A forecast from cannabis data researcher Headset indicates that the state’s adult-use market is set to produce US$215 million in revenue during its first year of operation.
Cannabis company news
- Delta 9 Cannabis (TSX:DN,OTCQX:DLTNF)will attempt to save between C$3 million and C$4 million. According to the firm, 40 employees at its Winnipeg facility will face “a temporary layoff” as output in the facility will drop 40 percent. “This was a very difficult decision, but it is a key component of executing on our strategic plan and one we believe best positions Delta 9 for profitable growth,” CEO John Arbuthnot said.
- Jushi Holdings (CSE:JUSH,OTCQX:JUSHF)confirmed significant management turnover with the appointment of Michelle Mosier as CFO, as well as the resignation of Leonardo Garcia-Berg as chief operations officer.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.